Zeeshan et al. reported that 13.5% of 89 CLL patients in their expressed ZAP-70 positivity and these patients had a higher absolute lymphocyte count and advanced clinical disease at the time of disease presentation compared to ZAP-70 negative patients [22]. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.